Teva Says FDA Approves Ajovy Autoinjector
28 Janvier 2020 - 11:16PM
Dow Jones News
By Stephen Nakrosis
Teva Pharmaceuticals USA, Inc. on Tuesday said the U.S. Food and
Drug Administration has granted approval to an autoinjector device
for Ajovy, or fremanezumab-vfrm.
Ajovy is a medication used to prevent migraines.
The Ajovy autoinjector is expected to be available to patients
in the coming months.
Teva Pharmaceuticals USA, Inc. is an affiliate of Teva
Pharmaceutical Industries Ltd. (TEVA).
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
January 28, 2020 17:01 ET (22:01 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
